132 related articles for article (PubMed ID: 3114800)
1. Increased sensitivity of mice to tremorogenic agents following MPP+.
Wagner GC; Walsh SL
Psychopharmacology (Berl); 1987; 92(4):470-2. PubMed ID: 3114800
[TBL] [Abstract][Full Text] [Related]
2. L-dopa reverses the effects of MPP+ toxicity.
Wagner GC; Jarvis MF; Rubin JG
Psychopharmacology (Berl); 1986; 88(3):401-2. PubMed ID: 3083462
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
4. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
[TBL] [Abstract][Full Text] [Related]
5. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with age.
Irwin I; Ricaurte GA; DeLanney LE; Langston JW
Neurosci Lett; 1988 Apr; 87(1-2):51-6. PubMed ID: 3260017
[TBL] [Abstract][Full Text] [Related]
7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver.
Thakar JH; Hassan MN; Grimes JD
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):355-62. PubMed ID: 3260387
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenylpyridinium (MPP+) increases oxidation of cytochrome-b in rat striatal slices.
Sanchez-Ramos JR; Hollinden GE; Sick TJ; Rosenthal M
Brain Res; 1988 Mar; 443(1-2):183-9. PubMed ID: 3258785
[TBL] [Abstract][Full Text] [Related]
9. Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice.
Sundström E; Goldstein M; Jonsson G
Eur J Pharmacol; 1986 Nov; 131(2-3):289-92. PubMed ID: 3493159
[TBL] [Abstract][Full Text] [Related]
10. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
Irwin I; Langston JW; DeLanney LE
Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
[TBL] [Abstract][Full Text] [Related]
11. Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats.
Subramanyam B; Rollema H; Woolf T; Castagnoli N
Biochem Biophys Res Commun; 1990 Jan; 166(1):238-44. PubMed ID: 2302206
[TBL] [Abstract][Full Text] [Related]
12. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
Hirata Y; Sugimura H; Takei H; Nagatsu T
Brain Res; 1986 Nov; 397(2):341-4. PubMed ID: 3099974
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
[TBL] [Abstract][Full Text] [Related]
14. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
Chang GD; Ramirez VD
Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
[TBL] [Abstract][Full Text] [Related]
15. MPP+ depletes retinal dopamine and induces D-1 receptor supersensitivity.
Qu ZX; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1988 Apr; 148(3):453-5. PubMed ID: 2968274
[TBL] [Abstract][Full Text] [Related]
16. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
[TBL] [Abstract][Full Text] [Related]
17. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
19. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
Samantaray S; Mohanakumar KP
Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
